All News

shoulder.exam_.jpg

ACR21 Previews from Creaky Joints

d Jack Cush, MD

CreakyJoints will present 11 posters and two oral presentations at ACR 2021. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system. 

Read Article
ACRmtg.jpg (keep)

Industry Press Releases - BMS, Abbvie, UCB, Janssen

d Jack Cush, MD

The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021.  Below is a listing of some of their best studies for you to review and look for in the meeting.

Read Article
Gout.T2T.jpg

Treat-to-Target Works in Gout With No Cardiac Toxicity

d ACR

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. Importantly, both urate-lowering therapies were very effective with 90% of patients reaching target urate levels. Additionally, both appeared safe, with no evidence of increased cardiovascular toxicity (Abstract #1900).

Read Article
exhibitor.floor.ACR

Industry Abstract Previews #ACR21 - Horizon, Aurinia, AstraZeneca

d Jack Cush, MD

The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021.  Below is a listing of some of their best studies for you to review and look for in the meeting.

Read Article
Telemedicine black computer

Negative Concerns of Telemedicine in Rheumatology

d Jack Cush, MD

Post-pandemic structured surveys and interviews with rheumatology patients suggests they may prefer for face-to-face consultations, as telehealth visits run the risk of diagnostic inaccuracies and safety concerns.

Read Article
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush. It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6

Links:

David Liew drdavidliew ( View Tweet)

Intensive RA Rx in the TITRATE study showed Disease activity & less remission in in obese patients, but Anxiety, depression and health perceptions were associated with higher pain and fatigue scores. These are unaccounted for in Rx strategies https://t.co/B8izEjfz8P

Links:

Dr. John Cush RheumNow ( View Tweet)

How I Treat Rheumatoid Arthritis My Stepwise Approach to DMARD, Biologic and Targeted Synthetic Use in RA patients QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 (November 5-9, 2021) https://t.co/jizbQ0Bgxq https://t.co/fXLheKv5dw

Links:

Dr. John Cush RheumNow ( View Tweet)
Treat-to-Target Works in Gout With No Cardiac Toxicity New research presented this week at ACR Convergence shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. #ARC21 Read more... https://t.co/r2usSxNnfZ https://t.co/GIgAP3T2hd

Links:

Dr. John Cush RheumNow ( View Tweet)
Industry Abstract Previews #ACR21 - Horizon, Aurinia, AstraZeneca Save The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021. https://t.co/ePZHXG5iih https://t.co/xxecyJzwkK

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

Negative Concerns of Telemedicine in Rheumatology Post-pandemic structured surveys and interviews with rheum patients suggests they may prefer for face-to-face consultations, as telehealth visits run the risk of diagnostic inaccuracies & safety concerns. https://t.co/FBZ2B1U6Ad https://t.co/1tX35jV76I

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

Pre-ACR is always a good time for a bit of a breath, so we can actually see the forest for the trees #ACR21 @RheumNow https://t.co/lKQF5GziyP
David Liew drdavidliew ( View Tweet)
New Download Available! The Scary Side of Steroid. Log in to RheumNow to download. https://t.co/0OfMAsFvWu https://t.co/FpT4aqV8pV

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: Scary Steroids QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 https://t.co/jnruS0m3Gr https://t.co/REMKWoR6DQ

Links:

Dr. John Cush RheumNow ( View Tweet)
#ACR21 is just days away and we want to see your best images of learning virtually, missing a meeting in San Francisco, wellness, or break time activities. Tweet your pic and make sure to include #RheumPix and #ACR21 and we’ll share our favorites. https://t.co/DTyOKrlG7J
Dr. John Cush RheumNow ( View Tweet)
Infection Rates in Psoriatic Arthritis Patients on Biologics Have Decreased #ACR21 https://t.co/dWrlIBHya7 https://t.co/U9hXcXUrI5

Links:

Dr. John Cush RheumNow ( View Tweet)
NOR-DRUM Study: TNF Inhibitor Therapeutic Drug Monitoring is Effective https://t.co/RPS6OiXsx2 #ACR21 https://t.co/uMv5LNq3Sh

Links:

Dr. John Cush RheumNow ( View Tweet)
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/IEjvmn7glF

Links:

Dr. John Cush RheumNow ( View Tweet)
×